The Current Therapeutic Landscape for CV Risk Reduction in Patients with Hypercholesterolemia: New Developments in LDL-Focused CV Risk Reduction in High Risk Populations—From Mechanism to Management

The Current Therapeutic Landscape for CV Risk Reduction in Patients with Hypercholesterolemia: New Developments in LDL-Focused CV Risk Reduction in High Risk Populations—From Mechanism to Management


Published

September 30, 2016

Created by

CMEducation Resources symposium